✦ LIBER ✦

Design of protease inhibitors

✍ Scribed by M. A. Ondetti; D. W. Cushman

Publisher: Wiley (John Wiley & Sons)
Year: 1981
Tongue: English
Weight: 519 KB
Volume: 20
Category: Article
ISSN: 0006-3525
DOI: 10.1002/bip.1981.360200922

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

There is a general parallelism in the strategy followed in the design of hormonal peptide analogs and protease inhibitors. However, in the latter, one more dimension has been added with the development of mechanism‐based inhibitors, a dimension that is not yet available for hormonal peptides because of the lack of knowledge about receptor mechanisms. The recently advanced concepts of transition state and bi‐product analogs have made possible the development of highly potent active‐site directed reversible protease inhibitors of great therapeutic potential.

📜 SIMILAR VOLUMES

Design of Translactam HCMV Protease Inhi

Design of Translactam HCMV Protease Inhibitors as Potent Antivirals

✍ Alan D. Borthwick 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

Design of translactam HCMV protease inhi

Design of translactam HCMV protease inhibitors as potent antivirals

✍ Alan D. Borthwick 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 908 KB

## Abstract Human cytomegalovirus (HCMV) is an important pathogen for which there is a significant unmet medical need. New HCMV antivirals, active against novel molecular targets, are undoubtedly needed as the currently available drugs ganciclovir, cidofovir, and foscarnet, which are all viral DNA

Design of protease inhibitors on the bas

Design of protease inhibitors on the basis of substrate stereospecificity

✍ Dong H. Kim 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 77 KB 👁 2 views

The substrate stereospecificity in enzymic reactions, which is one of characteristics of enzymes along with the substrate and regiospecificity can provide a basis for the rational design of inhibitors. This has been demonstrated using ␣-chymotrypsin, a prototypic serine protease as a model enzyme. O

Design, Synthesis and Evaluation of Seri

Design, Synthesis and Evaluation of Serine Protease Inhibitor Analogues

✍ Laila Kamoune; Wim M. De Borggraeve; Constant Gielens; Arnout Voet; Koen Robeyns 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

The Design of Potent, Non-Peptidic Inhib

The Design of Potent, Non-Peptidic Inhibitors of Hepatitis C Protease

✍ David M. Andrews; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 69 KB 👁 1 views

Isolation of Protease Inhibitors

✍ Dr. H. Fritz; H. Schult; M. Neudecker; Prof. E. Werle 📂 Article 📅 1966 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views